Medication reconciliation in pediatric patients with cancer at Brazilian public hospital

Objective: This study aims to describe the discrepancies found through medication reconciliation performed by a clinical pharmacist in pediatric patients admitted to an oncology public hospital. Methods: A descriptive cross-sectional study was carried out in a North Brazilian oncology public hospit...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nathalia S. PENHA, Marcos V. SILVA, Mayara A. BARROS, Tácio M. LIMA
Formato:	article
Lenguaje:	EN PT
Publicado:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2020
Materias:	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/e98a48c9686742859e84983e1f9e7ce4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e98a48c9686742859e84983e1f9e7ce4
record_format	dspace
spelling	oai:doaj.org-article:e98a48c9686742859e84983e1f9e7ce42021-11-28T02:44:54ZMedication reconciliation in pediatric patients with cancer at Brazilian public hospital10.30968/rbfhss.2020.113.03372179-59242316-7750https://doaj.org/article/e98a48c9686742859e84983e1f9e7ce42020-08-01T00:00:00Zhttps://www.rbfhss.org.br/sbrafh/article/view/337https://doaj.org/toc/2179-5924https://doaj.org/toc/2316-7750 Objective: This study aims to describe the discrepancies found through medication reconciliation performed by a clinical pharmacist in pediatric patients admitted to an oncology public hospital. Methods: A descriptive cross-sectional study was carried out in a North Brazilian oncology public hospital. Patients aged 0 – 19 years old with any cancer diagnosis and/or stage were interviewed by a clinical pharmacist within 24 hours of hospital admission about their current medication use in order to develop an updated list to be compared with the medical prescription. Medication discrepancies were classified according the medication discrepancy taxonomy (MedTax). Results: One hundred and sixty-seven patients were screened for eligibility criteria. Of those, 160 patients were included in this study, with a mean age of 7.2±4.2 years old; 58.2% were boys, taking a mean of 3.0±1.3 drugs, and the most frequent primary diagnosis presented were leukemias (46.9%) and malignant bone tumors (12.5%). One hundred and twenty discrepancies were identified, of which 92.0% were unintentional discrepancies. Among them, 72.7% classified as omission, followed by frequency and/or number of units of dosage form and/or total daily dose (16.2%), duration or length of therapy (7.2%), and drug duplication (3.9%). Ondansetron (37.3%) was the drug more involved in these discrepancies. Conclusion: This study presented high unintentional discrepancies between the updated medication list and the medical prescription in pediatric patients with cancer, most of which classified such as inclusion. Our findings showed the importance of the clinical pharmacist to minimize medication errors in these patients. Nathalia S. PENHAMarcos V. SILVAMayara A. BARROSTácio M. LIMASociedade Brasileira de Farmácia Hospitalar e Serviços de SaúdearticlePublic aspects of medicineRA1-1270Pharmacy and materia medicaRS1-441Therapeutics. PharmacologyRM1-950ENPTRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 11, Iss 3 (2020)
institution	DOAJ
collection	DOAJ
language	EN PT
topic	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950
spellingShingle	Public aspects of medicine RA1-1270 Pharmacy and materia medica RS1-441 Therapeutics. Pharmacology RM1-950 Nathalia S. PENHA Marcos V. SILVA Mayara A. BARROS Tácio M. LIMA Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
description	Objective: This study aims to describe the discrepancies found through medication reconciliation performed by a clinical pharmacist in pediatric patients admitted to an oncology public hospital. Methods: A descriptive cross-sectional study was carried out in a North Brazilian oncology public hospital. Patients aged 0 – 19 years old with any cancer diagnosis and/or stage were interviewed by a clinical pharmacist within 24 hours of hospital admission about their current medication use in order to develop an updated list to be compared with the medical prescription. Medication discrepancies were classified according the medication discrepancy taxonomy (MedTax). Results: One hundred and sixty-seven patients were screened for eligibility criteria. Of those, 160 patients were included in this study, with a mean age of 7.2±4.2 years old; 58.2% were boys, taking a mean of 3.0±1.3 drugs, and the most frequent primary diagnosis presented were leukemias (46.9%) and malignant bone tumors (12.5%). One hundred and twenty discrepancies were identified, of which 92.0% were unintentional discrepancies. Among them, 72.7% classified as omission, followed by frequency and/or number of units of dosage form and/or total daily dose (16.2%), duration or length of therapy (7.2%), and drug duplication (3.9%). Ondansetron (37.3%) was the drug more involved in these discrepancies. Conclusion: This study presented high unintentional discrepancies between the updated medication list and the medical prescription in pediatric patients with cancer, most of which classified such as inclusion. Our findings showed the importance of the clinical pharmacist to minimize medication errors in these patients.
format	article
author	Nathalia S. PENHA Marcos V. SILVA Mayara A. BARROS Tácio M. LIMA
author_facet	Nathalia S. PENHA Marcos V. SILVA Mayara A. BARROS Tácio M. LIMA
author_sort	Nathalia S. PENHA
title	Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
title_short	Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
title_full	Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
title_fullStr	Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
title_full_unstemmed	Medication reconciliation in pediatric patients with cancer at Brazilian public hospital
title_sort	medication reconciliation in pediatric patients with cancer at brazilian public hospital
publisher	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
publishDate	2020
url	https://doaj.org/article/e98a48c9686742859e84983e1f9e7ce4
work_keys_str_mv	AT nathaliaspenha medicationreconciliationinpediatricpatientswithcanceratbrazilianpublichospital AT marcosvsilva medicationreconciliationinpediatricpatientswithcanceratbrazilianpublichospital AT mayaraabarros medicationreconciliationinpediatricpatientswithcanceratbrazilianpublichospital AT taciomlima medicationreconciliationinpediatricpatientswithcanceratbrazilianpublichospital
_version_	1718408473335562240

Medication reconciliation in pediatric patients with cancer at Brazilian public hospital

Ejemplares similares